HIV Citation List: February 14 - February 27, 2014

PubMed citations

1. Dual Inhibition of HCV and HIV by Ring-expanded Nucleosides Containing the 5:7-Fused imidazo[4,5-e][1,3]diazepine Ring System. In Vitro Results and Implications. Zhang, N., P. Zhang, A. Baier, L. Cova, and R.S. Hosmane. Bioorganic & Medicinal Chemistry Letters, 2014. 24(4): p. 1154-1157. PMID[24461293].

[PubMed]. HIV_0214-022714.

2. High-affinity Recognition of HIV-1 Frameshift-stimulating RNA Alters Frameshifting in Vitro and Interferes with HIV-1 Infectivity. Ofori, L.O., T.A. Hilimire, R.P. Bennett, N.W. Brown, Jr., H.C. Smith, and B.L. Miller. Journal of Medicinal Chemistry, 2014. 57(3): p. 723-732. PMID[24387306].

[PubMed]. HIV_0214-022714.

3. Design and Synthesis of N1-Aryl-benzimidazoles 2-Substituted as Novel HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors. Monforte, A.M., S. Ferro, L. De Luca, G. Lo Surdo, F. Morreale, C. Pannecouque, J. Balzarini, and A. Chimirri. Bioorganic & Medicinal Chemistry, 2014. 22(4): p. 1459-1467. PMID[24457088].

[PubMed]. HIV_0214-022714.

4. Preparation and Activities of Macromolecule Conjugates of the CCR5 Antagonist Maraviroc. Asano, S., J. Gavrilyuk, D.R. Burton, and C.F. Barbas, 3rd. ACS Medicinal Chemistry Letters, 2014. 5(2): p. 133-137. PMID[24563723].

[PubMed]. HIV_0214-022714.

ISI Web of Knowledge Citations

5. An Asymmetric Allylic Alkylation-smiles Rearrangement-sulfinate Addition Sequence to Construct Chiral Cyclic Sulfones. Wang, Q.G., Q.Q. Zhou, J.G. Deng, and Y.C. Chen. Organic Letters, 2013. 15(18): p. 4786-4789. ISI[000330159700041].

[WOS]. HIV_0214-022714.

6. Evaluation of Baylis-Hillman Routes to 3-(Aminomethyl) Coumarin Derivatives. Olasupo, I., N.R. Rose, R. Klein, L.A. Adams, O.B. Familoni, and P.T. Kaye. Synthetic Communications, 2014. 44(2): p. 251-258. ISI[000330016100012].

[WOS]. HIV_0214-022714.

7. Sulfated Polysaccharides as Bioactive Agents from Marine Algae. Ngo, D.H. and S.K. Kim. International Journal of Biological Macromolecules, 2013. 62: p. 70-75. ISI[000329881200012].

[WOS]. HIV_0214-022714.

8. Preparation of Spiro[4.4]-Oxaphospholene and -Azaphospholene Systems from Carbohydrate Templates. Moura, M., S. Josse, and D. Postel. Journal of Organic Chemistry, 2013. 78(18): p. 8994-9003. ISI[000330159500006].

[WOS]. HIV_0214-022714.

9. Dead-end Complexes Contribute to the Synergistic Inhibition of HIV-1 RT by the Combination of Rilpivirine, Emtricitabine, and Tenofovir. Kulkarni, R., J.Y. Feng, M.D. Miller, and K.L. White. Antiviral Research, 2014. 101: p. 131-135. ISI[000329772700017].

[WOS]. HIV_0214-022714.

10. Inhibition of Reverse Transcriptase and Taq DNA Polymerase by Compounds Possessing the Coumarin Framework. Hugo, A.G., M.M. Jimena, M.C. Gladys, E.T. Carlos, and R.P. Carlos. Bioorganic & Medicinal Chemistry Letters, 2014. 24(3): p. 760-764. ISI[000330120800010].

[WOS]. HIV_0214-022714.

11. Synthesis and Biological Study of O-beta-D-Glucosides of 7-Hydroxy-3-(disubstituted imidazol-2-yl)-4H-chromen-4-ones. Hatzade, K.M., V.S. Taile, and V.N. Ingle. Macroheterocycles, 2013. 6(2): p. 192-198. ISI[000330121400011].

[WOS]. HIV_0214-022714.

12. Cyclophilin A Inhibitors as Potential anti-HIV Agents. Gupta, M., D. Shah, P.T. Flaherty, and Z. Ambrose. Abstracts of Papers of the American Chemical Society, 2013. 246. ISI[000329618404717].

[WOS]. HIV_0214-022714.

13. Hydroxy Fatty acids for the Delivery of Dideoxynucleosides as anti-HIV Agents. Gangadhara, K.L., E. Lescrinier, C. Pannecouque, and P. Herdewijn. Bioorganic & Medicinal Chemistry Letters, 2014. 24(3): p. 817-820. ISI[000330120800020].

[WOS]. HIV_0214-022714.

14. Cytotoxic, Cytostatic and HIV-1 PR Inhibitory Activities of the Soft Coral Litophyton arboreum. Ellithey, M.S., N. Lall, A.A. Hussein, and D. Meyer. Marine Drugs, 2013. 11(12): p. 4917-4936. ISI[000330220400014].

[WOS]. HIV_0214-022714.

15. Simultaneous Zinc-finger Nuclease Editing of the HIV Coreceptors CCR5 and CXCR4 Protects CD4(+) T Cells from HIV-1 Infection. Didigu, C.A., C.B. Wilen, J.B. Wang, J. Duong, A.J. Secreto, G.A. Danet-Desnoyers, J.L. Riley, P.D. Gregory, C.H. June, M.C. Holmes, and R.W. Doms. Blood, 2014. 123(1): p. 61-69. ISI[000329742300015].

[WOS]. HIV_0214-022714.

16. Conformational Preferences of the Aryl-x-aryl Motif: Evolution of Potent Next Generation HIV-1 Nonnucleoside Reverse Transcriptase Inhibitors (NNRTI's) That Contain a Biaryl Ether. Anthony, N.J. Abstracts of Papers of the American Chemical Society, 2013. 246. ISI[000329618404861].

[WOS]. HIV_0214-022714.